期刊文献+

有序介孔二氧化硅改善双嘧达莫的溶出速率 被引量:5

Research on improving dissolution rate of dipyridamole with ordered mesoporous silica
原文传递
导出
摘要 目的:制备有序介孔二氧化硅FDU-12改善双嘧达莫的溶出速率。方法:使用三嵌段共聚物F127和1,3,5-三甲苯制备FDU-12,并以FDU-12为载体,通过吸附平衡法将双嘧达莫(DP)载入FDU-12孔道中。使用透射电镜观察载体FDU-12的形态和结构,并通过氮气吸附和脱吸附分析测定FDU-12的孔径及比表面积,应用差示扫描量热法,X射线衍射法和傅里叶红外光谱法分析载药样品(FDU-DP)中药物的存在状态,并通过体外溶出实验考察其体外溶出度。结果:结构表征证明成功制备了FDU-12,并且FDU-12的介孔孔道有效抑制了双嘧达莫重结晶。体外溶出试验表明双嘧达莫的溶出速率得到显著的提高。结论:FDU-12改善了水难溶性药物双嘧达莫的溶出速率。 Objective: To prepare ordered mesoporous silica FDU-12 to improve the dissolution rate of dipyridamole. Methods: FDU-12 that acted as a carrier was synthesized using Pluronic F127 triblock copolymer and 1,3,5-trimethylbenzene. Dipyridamole( DP) was loaded onto FDU-12 by adsorption equilibrium method. The structure and morphology of the FDU-12 were investigated by transmission electron microscopy. Nitrogen adsorption / desorption analysis determined the pore size and specific surface area of FDU-12. Differential scanning calorimetry,powder X-ray diffraction and fourier transform infrared spectroscopy were used to analyze the existing state of dipyridamole in drug-loaded sample( FDU-DP). In vitro dissolution experiment was performed to determine the dissolution rate. Results: FDU-12 was synthesized successfully and the mesopores effectively suppressed crystallinity of dipyridamole by structure characterization. The in vitro dissolution test showed that the dissolution rate of dipyridamole was improved significantly. Conclusion: FDU-12 is thought to be a promising way to improve the dissolution rate of dipyridamole.
出处 《中国新药杂志》 CAS CSCD 北大核心 2015年第17期2036-2040,共5页 Chinese Journal of New Drugs
基金 辽宁省大学生创新创业训练计划项目(201310160027) 校长基金-奥鸿博泽基金-医药创新专项(XZJJ20130104-07)
关键词 有序介孔二氧化硅 FDU-12 双嘧达莫 水难溶性药物 溶出速率 ordered mesoporous silica FDU-12 dipyridamole poorly water-soluble drugs dissolution rate
  • 相关文献

参考文献18

  • 1FUKAWA K, SAITOH K, IRINO O,et al. Inhibitory mechanism of dipyridamole on platelet aggregation ox vivo[J]. Thromb Res, 1982,27 (3) :333 - 340.
  • 2HARKER LA,KADATZ RA. Mechanism of action of dipyridamole [J]. Thromb Res Suppl,1983 ,4:39 -46.
  • 3ZHANG Y,JIANG T,ZHANG Q,et al. Inclusion of telmisartan in mesoeellular foam nanopartieles: drug loading and release property[ J]. Eur J Pharm Biopharm,2010,76 ( 1 ) : 17 - 23.
  • 4RODRIGUEZ-ALLER M, KAUFMANN B, GUILLARME D,et al. In vlvo charaeterisation of a novel water-soluble Cyclosporine A prodrug for the treatment of dry eye disease [ J]. Eur J Pharm Biopharm ,2012,80 ( 3 ) :544 - 552.
  • 5平其能.纳米药物和纳米载体系统[J].中国新药杂志,2002,11(1):42-46. 被引量:60
  • 6VASCONCELOS T,SARMENTO B,COSTA P. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs [ J ]. Drug Discov Today,2007,12 ( 23 - 24) : 1068 - 1075.
  • 7MODI S,XIANG TX, ANDERSON BD. Enhanced active liposo- mal loading of a poorly soluble ionizable drug using supersaturated drug solutions[ J]. J Control Release,2012,162(2) :330 -339.
  • 8VOGT M, KUNATH K, DRESSMAN JB. Dissolution enhance-ment of fenofibrate by micronization, cogrinding and spray-drying: comparison with commercial preparations[ J]. Eur J Pharm Biop- harm ,2008,68 (2) :283 - 288.
  • 9KAPOOR S, HEGDE R, BHATTACHARYYA AJ. Influence of surface chemistry of mesoporous alumina with wide pore distribu- tion on controlled drug release [ J]. J Control Release,2009,140 (1) :34 -39.
  • 10JIANG H, WANG T, WANG L, et al. Development of an amor- phous mesoporous TiO2 nanosphere as a novel carrier for poorly water-soluble drugs : effect of different crystal forms of TiO2 carri- ers on drug loading and release behaviors [ J]. Micropor and Me- sopor Mat,2012, 153 ( 1 ) : 124 - 130.

二级参考文献13

共引文献60

同被引文献42

  • 1JIA ZR,LIN P,XIANG Y,et al.A novel nanomatrix system consisted of colloidal silica and pH-sensitive polymethylacrylate improves the oral bioavailability of fenofibrate[J].Biopharmaceutics,2011,79(1):126-134.
  • 2LI HC,SAKAMOTO Y,LI YS,et al.Synthesis of carbon replicas of SBA-1 and SBA-7 mesoporous silicas[J].Micropor Mesopor Mat,2006,95(1-3):193-199.
  • 3MOHAMMAD BJ,SAEED G,KHOSRO A,et al.Development and characterization of solid dispersion of piroxicam for improvement of dissolution rate using hydrophilic carriers[J].Bioimpacts,2014,4(3):141-148.
  • 4WU C,ZHAO ZZ,ZHAO Y,et al.Preparation of a push-pull osmotic pump of felodipine solubilized by mesoporous silica nanoparticles with a core-shell structure[J].Int J Pharm,2014,475(1-2):298-305.
  • 5LIU DF,BIMBO LM,MAKILA E,et al.Co-delivery of a hydrophobic small molecule and a hydrophilic peptide by porous silicon nanoparticles[J].J Control Release,2013,170(2):268-278.
  • 6SAREEN S,MUTREJA V,PAL B,et al.Homogeneous dispersion of Au nanoparticles into mesoporous SBA-15 exhibiting improved catalytic activity for nitroaromatic reduction[J].Micropor Mesopor Mat,2015,202(15):219-225.
  • 7MALEKI A,HAMIDI M.Dissolution enhancement of a model poorly water-soluble drug,atorvastatin,with ordered mesoporous silica:comparison of MSF with SBA-15 as drug carriers[J].Expert Opin Drug Del,2016,13(2):171-181.
  • 8ZHAO P,JIANG H,JIANG T,et al.Inclusion of celecoxib into fibrous ordered mesoporous carbon for enhanced oral bioavailability and reduced gastric irritancy[J].Eur J Pharm Sci,2012,45(5):639-647.
  • 9BOULEDJOUIDJA A,MASMOUDI Y,VAN SM,et al.Impregnation of fenofibrate on mesoporous silica using supercritical carbon dioxide[J].Int J Pharm,2016,499(1-2):1-9.
  • 10ZHAO Y,WU C,ZHAO Z,et al.Preparation of starch macrocellular foam for increasing the dissolution rate of poorly water-soluble drugs[J].Pharm Dev Technol,2016,21(6):749-754.

引证文献5

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部